Grail's Next-Gen Multi-Cancer Test Detects 50 Early-Stage Cancers with 93% Accuracy

GRAIL published validation data for its multi-cancer early detection blood test. The technology can detect more than 50 different cancer types across all stages. It has a false-positive rate of less than one percent and does all this testing on a single blood sample. It reports that in positive results, it is 93% accurate.